AstraZeneca Ineffective VS South African Strain According To Study
ASTRAZENECA INEFFECTIVE – According to a study published in the New England Journal of Medicine, the AstraZeneca vaccine “did not show protection” against the South African COVID-19 strain.
The results suggested that the virus provided little to no efficacy versus mild-to-moderate cases of the strain. The study explained that the efficacy on the number of vaccinated people and the test group weren’t significant different from each other.
Furthermore, the study revealed that the vaccine had difficulties in neutralizing the South African variant. Meanwhile, AstraZeneca responded saying their vaccine could still protect versus severe disease and hospitalization caused by the strain.
Likewise, the study wrote that “there were no cases of hospitalization for sever COVID-19 observed in the study”.
Much like Sinovac, AstraZeneca also showed a lower efficacy rating for mild-to-moderate cases. However, both firms believed their vaccines to be effective when it comes to severe cases.
In the Philippines, the South African strain has already been detected. Following this, there was a significant increase in the number of COVID-19 cases reported. Additionally, a new COVID-19 variant distinct to the Philippines was discovered.
Thanks for reading. We aim to provide our readers with the freshest and most in-demand content. Come back next time for the latest news here on Philnews.